| teniposide | <chemical> A cytotoxic semisynthetic derivative of podophyllotoxin that may be effective in cancer chemotherapy. It prevents cells from entering the prophase of mitosis and inhibits DNA synthesis. Pharmacological action: antineoplastic agent, phytogenic, nucleic acid synthesis inhibitors. Chemical name: Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-((4,6-O-(2-thienylmethylene)-beta-D-glucopyranosyl)oxy)-, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))- (12 Dec 1998) |
|---|
Synonyms : Bristol-Myers Brand of Teniposide, Bristol-Myers Squibb Brand of Teniposide, NSC-122819, Teniposide, (5a alpha, 9 alpha(S*))-Isomer, VM-26, Vumon, Bristol Myers Brand of Teniposide, Bristol Myers Squibb Brand of Teniposide, NSC 122819, NSC122819, VM 26, VM26
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
부몬주 - 새창
|
BMS |
E00140101 | Teniposide | 전문의약품 | 급여 | 분업예외의약품 |
| teniposide |
An anticancer drug that is a podophyllotoxin derivative and belongs to the family of drugs called mitotic inhibitors.
출처: www.stjude.org/glossary
|
|---|---|
| teniposide |
A chemotherapy drug that inhibits cancer cell growth by interfering with the formation of DNA.
출처: nydailynews.healthology.com/nydailynews/15836.htm
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|